Expectations and positive emotional feelings accompany reductions in ongoing and evoked neuropathic pain following placebo interventions

Pain

Volumn 155, Issue 12, 2014, Pages 2687-2698

  Petersen, Gitte L ^a,b   Finnerup, Nanna B ^b   Grosen, Kasper ^b   Pilegaard, Hans K ^b   Tracey, Irene ^c   Benedetti, Fabrizio ^d   Price, Donald D ^e   Jensen, Troels S ^b   Vase, Lene ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Emotional feelings; Expectation; Neuropathic pain; Nocebo hyperalgesia; Placebo analgesia

Indexed keywords

CAPSAICIN; LIDOCAINE; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; LOCAL ANESTHETIC AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; EMOTION; EXPECTATION; EXPERIENTIAL LEARNING; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; NOCEBO EFFECT; NOCICEPTION; OUTCOME ASSESSMENT; PAIN INTENSITY; PATIENT ASSESSMENT; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THORACOTOMY; TOPICAL TREATMENT; VISUAL ANALOG SCALE; ADVERSE EFFECTS; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POSTOPERATIVE COMPLICATIONS; PSYCHOLOGIC TEST; PSYCHOLOGY; STIMULATION; THORAX DRAINAGE;

ADULT; AGED; ANESTHETICS, LOCAL; CAPSAICIN; EMOTIONS; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; NOCEBO EFFECT; PAIN MEASUREMENT; PHYSICAL STIMULATION; PLACEBO EFFECT; POSTOPERATIVE COMPLICATIONS; PSYCHOLOGICAL TESTS; SENSORY SYSTEM AGENTS; THORACOSTOMY;

EID: 84922704791     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.09.036     Document Type: Article

References (68)

1. ® 2001;90:205-15.
2. Baron R, Guy H, Dickenson AH. Peripheral input and its importance for central sensitization. Ann Neurol 2013;74:630-6.
3. Barrell JJ, Barrell JE. A self-directed approach for a science of human experience. J Phenomenol Psychol 1975; Fall: 63-73.
4. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 2008;48:33-60.
5. Benedetti F. Placebo effects. Understanding the mechanisms in health and disease. Oxford University Press; 2009.
6. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-23.
7. Bennett GJ. What is spontaneous pain and who has it? J Pain 2012;13:921-9.
8. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 1988.
9. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004;3:679-84.
10. ® 2010;151:430-9.
11. ® 2008;136:211-8.
12. Craggs JG, Price DD, Verne GN, Perlstein WM, Robinson MM. Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia. Neuroimage 2007;38:720-9.
13. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2009;4: CD007393.
14. Dirks J, Petersen KL, Dahl JB. The heat/capsaicin sensitization model: a methodologic study. J Pain 2003;3:122-8.
15. ® 2010;149:177-93.
16. Eippert F, Finsterbusch J, Bingel U, Büchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science 2009;326:404.
17. Elsenbruch S, Schmid J, Bäsler M, Ceso E, Schedlowski M, Benson S. How positive and negative expectations shape the experience of visceral pain: an experimental pilot study in healthy women. Neurogastroenterol Motil 2012;24:e460.
18. Fields HL, Price DD. Toward a neurobiology of placebo analgesia. In: Harrington A, editor. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press; 1997. p. 93-116.
19. Flaten MA, Aslaksen PM, Finset A, Simonsen T, Johansen O. Cognitive and emotional factors in placebo analgesia. J Psychosom Res 2006;61:81-9.
20. Flaten MA, Aslaksen PM, Lyby PS, Bjørkedal E. The relation of emotions to placebo analgesia. Philos Trans R Soc Lond B Biol Sci 2011;366:1818-27.
21. Flaten MA, Colloca L, Meissner K, editors. Placebo and pain: from bench to bedside. New York: Elsevier; 2013.
22. Gröne E, Crispin A, Fleckenstein J, Irnich D, Treede RD, Lang PM. Test order of quantitative sensory testing facilitates mechanical hyperalgesia in healthy volunteers. J Pain 2012;13:73-80.
23. Hurlburt RT. Investigating pristine inner experience: moments of truth. New York: Cambridge University Press; 2011.
24. Hurlburt RT, Heavey CL Telling what we know: describing inner experience. Trends Cogn Sci 2001;5:400-3.
25. Hurlburt RT, Heavey CL Exploring inner experience. Amsterdam: John Benjamins; 2006.
26. Hurlburt RT, Koch M, Heavey CL. Descriptive experience sampling demonstrates the connection of thinking to externally observable behavior. Cogn Therapy Res 2002;26:117-34.
27. Jensen KB, Petrovic P, Kerr CE, Kirsch I, Raicek J, Cheetham A, Spaeth R, Cook A, Gollub RL, Kong J, Kaptchuk TJ. Sharing pain and relief: neural correlates of physicians during treatments of patients. Mol Psychiatry 2014;19:392-8.
28. ® 2011;152:2204-5.
29. Johansen O, Brox J, Flaten MA. Placebo and nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med 2003;65:786-90.
30. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010;5:e15591.
31. Klinger R, Schmitz J, Benson S, Elsenbruch S, Kamping S, Flor H. Schmerzreduktion durch Variation von Kontextreizen: Möglichkeiten zur Selbstwirksamkeit in der Schmerztherapie? der Schmerz 2013:47-9.
32. Kong J, Gollub RL, Polich G, Kirsch I, La Violette P, Vangel M, Rosen B, Kaptchuk TJ. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 2008;28:13354-62.
33. Krumova EK, Geber C, Westermann A, Maier C. Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep 2012;12:393-402.
34. Kupers R, Maeyaert J, Boly M, Faymonville ME, Laureys S. Naloxone-insensitive epidural placebo analgesia in a chronic pain patient. Anesthesiology 2007;106:1239-42.
35. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10:895-926.
36. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978;2:654-7.
37. ® 1999;79:75-82.
38. ® 2012;153:1114-21.
39. Lyby PS, Aslaksen PM, Flaten MA. Is fear of pain related to placebo analgesia? J Psychosom Res 2010;68:369-77.
40. Madsen CS, Johnsen B, Fuglsang-Frederiksen A, Jensen TS, Finnerup NB. Increased contact heat pain and shortened latencies of contact heat evoked potentials following capsaicin-induced heat hyperalgesia. Clin Neurophysiol 2012;123:1429-36.
41. Martini CH, Yassen A, Krebs-Brown A, Passier P, Stoker M, Olofsen E, Dahan A. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. Eur J Pain 2013;17:1491-501.
42. ® 1997;72:107-13.
43. Morton DL, Brown CA, Watson A, El-Deredy W, Jones AK. Cognitive changes as a result of a single exposure to placebo. Neuropsychologia 2010;48:1958-64.
44. ® 2012;153:1292-300.
45. Petersen KL, Rowbotham MC. A new human experimental pain model: the heat/capsaicin sensitization model. Neuroreport 1999;10:1511-6.
46. Piche M, Bouin M, Arsenault M, Poitras P, Rainville P. Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience 2011;195C: 166-75.
47. Price DD. Psychological mechanisms of pain and analgesia. Seattle: IASP Press; 1999.
48. Price DD, Barrell JJ. An experiential approach with quantitative methods: a research paradigm. J Humanist Psychol 1980;20:75-95.
49. Price DD, Barrell JJ. Some general laws of human emotion: interrelationships between intensities of desire, expectation and emotional feeling. J Pers 1984;52:389-409.
50. Price DD, Barrell JJ. Inner experience and neuroscience: merging both perspectives. Cambridge, MA: MIT Press; 2012.
51. Price DD, Barrell JJ, Rainville P. Integrating experiential-phenomenological methods and neuroscience to study neural mechanisms of pain and consciousness. Conscious Cogn 2002;11:593-608.
52. ® 1994;56:217-26.
53. ® 2007;127:63-72.
54. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008;59:565-90.
55. ® 1987;28:297-307.
56. ® 1999;83:147-56.
57. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Exp Rev Neurother 2009;9:745-58.
58. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995;3:246-53.
59. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007;55:325-36.
60. ® 2001;91:165-75.
61. Staud R, Weyl EE, Riley 3rd JL, Fillingim RB. Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients. PLoS One 2014;9:e89086.
62. Treede RD, Jensen TS, Campbell JN, Crucco G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5.
63. Vase L, Nørskov KN, Petersen GL, Price DD. Patients' direct experiences as central elements of placebo analgesia. Philos Trans R Soc Lond B Biol Sci 2011;366:1913-21.
64. ® 2003;105:17-25.
65. ® 2005;115:338-47.
66. ® 2003;105:223-30.
67. ® 2011;152:314-9.
68. Wade JB, Riddle DL, Thacker LR. Is pain catastrophizing a stable trait or dynamic state in patients scheduled for knee arthroplasty? Clin J Pain 2012;28:122-8.